Mativ Announces Third Quarter 2024 Results
Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding. "Comparable" non-GAAP measures used to compare current period
Mativ Third Quarter 2024 Highlights (Continuing Operations)
-
Sales of
$498.5 million increased 0.1% year over year, and 1.4% on an organic basis -
GAAP loss was
$20.8 million in Q3 2024, an improvement of$443.5 million compared to$464.3 million in the prior year (which included a$401.0 million goodwill impairment charge), GAAP EPS was$(0.38) ; both included organizational realignment, impairment, divestiture and purchase accounting expenses -
Adjusted income was
$11.0 million , Adjusted EPS was$0.21 , and Adjusted EBITDA was$60.8 million (see non-GAAP reconciliations) - Adjusted EBITDA was up 10% versus the prior year, primarily driven by improved manufacturing performance, lower SG&A and distribution expenses, partially offset by lower volumes in advanced films, and less favorable mix
-
GAAP operating profit margin improved materially compared to the prior year (which included a
$401.0 million goodwill impairment charge) and adjusted EBITDA margin increased 110 basis points
Management Commentary
Chief Executive Officer
Given the prevailing macro-economic conditions and the slow pace of demand recovery, we continue to prioritize those things that we can control and execute on actions to mitigate external market factors, such as the
Mativ Third Quarter 2024 Financial Results (Continuing Operations)
Note: The Financial Results below reflect consolidated
Filtration & Advanced Materials (FAM) |
Three Months Ended |
||||||||||||||||
(in millions; unaudited) |
2024 |
|
2023 |
|
Change |
|
2024 |
|
2023 |
||||||||
|
$ |
189.6 |
|
$ |
195.8 |
|
$ |
(6.2 |
) |
|
|
|
|
||||
GAAP Operating Profit & Margin % |
$ |
19.9 |
|
$ |
22.6 |
|
$ |
(2.7 |
) |
|
10.5 |
% |
|
11.5 |
% |
||
Adjusted EBITDA & Margin % |
$ |
36.5 |
|
$ |
39.2 |
|
$ |
(2.7 |
) |
|
19.3 |
% |
|
20.0 |
% |
Filtration & Advanced Materials (FAM)
segment sales, comprised primarily of filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, were
GAAP Operating Profit in 2024 included
Sustainable & Adhesive Solutions (SAS) |
Three Months Ended |
||||||||||||||||
(in millions; unaudited) |
2024 |
|
2023 |
|
Change |
|
2024 |
|
2023 |
||||||||
|
$ |
308.9 |
|
$ |
302.4 |
|
|
$ |
6.5 |
|
|
|
|
||||
GAAP Operating Profit & Margin % |
$ |
10.3 |
|
$ |
(405.8 |
) |
|
$ |
416.1 |
|
3.3 |
% |
|
(134.2 |
)% |
||
Adjusted EBITDA & Margin % |
$ |
41.0 |
|
$ |
34.2 |
|
|
$ |
6.8 |
|
13.3 |
% |
|
11.3 |
% |
Sustainable & Adhesive Solutions (SAS)
segment sales, comprised primarily of tapes, labels, liners, specialty paper, packaging and healthcare solutions, of
GAAP Operating Profit in 2024 included
Unallocated |
Three Months Ended |
||||||||||||||||
(in millions; unaudited) |
2024 |
|
2023 |
|
Change |
|
2024 |
|
2023 |
||||||||
GAAP Operating Expense & % of Sales |
$ |
(23.2 |
) |
|
$ |
(36.7 |
) |
|
$ |
13.5 |
|
(4.7 |
)% |
|
(7.4 |
)% |
|
Adjusted EBITDA & % of Sales |
$ |
(16.7 |
) |
|
$ |
(18.0 |
) |
|
$ |
1.3 |
|
(3.4 |
)% |
|
(3.6 |
)% |
Adjusted unallocated expenses (EBITDA)
(see non-GAAP reconciliations) were in line with prior year. GAAP operating expenses in 2024 included
Interest
expense
was
Other expense, net
was
Tax rate
was 13.3% for the three months ended
Non-GAAP Adjustments reflect items included in GAAP operating profit, income, and EPS, but excluded from adjusted results (see non-GAAP reconciliation tables for additional details). The most significant adjustments to the third quarter 2024 results were as follows:
-
$0.22 per share of purchase accounting expenses (purchase accounting expenses reflect primarily ongoing non-cash intangible asset amortizations associated with mergers and acquisitions) -
$0.20 per share of restructuring, restructuring related, impairment, and other expenses
Cash Flow & Debt
Year-to-date 2024 cash provided by operating activities was
Total debt was
Dividend & Share Repurchases
On
During the third quarter, the company did not repurchase shares. The Company intends to repurchase shares periodically and opportunistically to offset dilution due to stock compensation.
Conference Call
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by that Act and other legal protections. Forward-looking statements include, without limitation, those regarding EPS and other financial guidance, acquisition integration and performance, growth prospects, future end-market trends, future macro-economic trends, the future effects of supply chain challenges and price increases, future cash flows, net leverage, purchase accounting impacts, effective tax rates, planned investments, profitability, and cash flow, the expected benefits of the Neenah merger and integration, whether the strategic benefits and accretion of the sale of the Company's Engineered Papers business can be achieved, the expected benefits, of our organizational restructuring, our ability to execute our growth strategy for 2024, and integration and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically," and similar words. In addition, the amount of the goodwill impairment charge previously announced is based in part on estimates of future performance, so this announcement should also be considered a forward-looking statement.
These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which
- Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
-
Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of
Mativ , including the recent EP divestiture; - Adverse changes in our end-market sectors impacting key customers;
- Changes in the source and intensity of competition in our commercial end-markets;
- Adverse changes in sales or production volumes, pricing and/or manufacturing costs;
- Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
- Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
- Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
- Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
- Our ability to attract and retain key personnel, labor shortages, labor strikes, stoppages or other disruptions;
-
Changes in general economic, financial and credit conditions in the
U.S. ,Europe ,China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro) and on interest rates; - A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
- Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
-
Changes in tax rates, the adoption of new
U.S. or international tax legislation or exposure to additional tax liabilities; -
Uncertainty as to the long-term value of the common stock of
Mativ ; -
Changes in employment, wage and hour laws and regulations in the
U.S. and elsewhere, including the unionization rules and regulations by theNational Labor Relations Board , equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws; - The impact of tariffs, and the imposition of any future additional tariffs and other trade barriers, and the effects of retaliatory trade measures;
- Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
- Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
-
International conflicts and disputes, such as the ongoing conflict between
Russia andUkraine , the war betweenIsrael andHamas and the broader regional conflict in theMiddle East , which restrict our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions; - Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
- Risks associated with pandemics and other public health emergencies, including the COVID-19 pandemic and its variant strains;
- The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs;
- Increased scrutiny from stakeholders related to environmental, social and governance (“ESG”) matters, as well as our ability to achieve our broader ESG goals and objectives;
- Costs and timing of implementation of any upgrades or changes to our information technology systems;
- Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
- The impact of cybersecurity risks related to breaches of security pertaining to sensitive Company, customer or vendor information, as well as breaches in the technology that manages operations and other business processes; and
-
Other factors described elsewhere in this document and from time to time in documents that we file with the
U.S. Securities and Exchange Commission (the “SEC”).
All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data. The financial results reported in this release are unaudited.
Non-GAAP Financial Measures
Certain financial measures and comments contained in this press release exclude restructuring and impairment expenses, certain purchase accounting adjustments related to prior acquisitions, organizational realignment and integration costs, divestiture costs, interest expense, stock compensation expense, inventory step-up expense, the effect of income tax provisions and other tax impacts, capital spending, capitalized software costs, cloud-based software costs and depreciation and amortization. This press release also provides certain information regarding the Company's financial results excluding currency impacts. This information estimates the impact of changes in foreign currency rates on the translation of the Company's current financial results as compared to the applicable comparable period and is derived by translating the current local currency results into
The Company believes that the presentation of non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency on the information used by the Company’s management in its financial and operational decision-making. Management also believes that the non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company’s financial and operational performance in the same way that management evaluates the Company's financial performance. Management believes that providing this information enables investors to better understand the Company’s operating performance and financial condition. These non-GAAP financial measures are not calculated or presented in accordance with, and are not intended to be considered in isolation or as alternatives or substitutes for, or superior to, financial measures prepared and presented in accordance with GAAP, and should be read only in conjunction with the Company's financial measures prepared and presented in accordance with GAAP. The non-GAAP financial measures used in this release may be different from the measures used by other companies.
CONSOLIDATED STATEMENTS OF INCOME (LOSS) FROM CONTINUING OPERATIONS (in millions, except per share amounts) (Unaudited) |
|||||||||||||||||||
|
|||||||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
% Change |
|
|
2024 |
|
|
|
2023 |
|
|
% Change |
Net sales |
$ |
498.5 |
|
|
$ |
498.2 |
|
|
0.1% |
|
$ |
1,522.5 |
|
|
$ |
1,573.7 |
|
|
(3.3)% |
Cost of products sold |
|
404.9 |
|
|
|
411.5 |
|
|
(1.6)% |
|
|
1,236.0 |
|
|
|
1,303.8 |
|
|
(5.2)% |
Gross profit |
|
93.6 |
|
|
|
86.7 |
|
|
8.0% |
|
|
286.5 |
|
|
|
269.9 |
|
|
6.2% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Selling expense |
|
18.1 |
|
|
|
20.5 |
|
|
(11.7)% |
|
|
54.6 |
|
|
|
60.6 |
|
|
(9.9)% |
Research and development expense |
|
5.7 |
|
|
|
5.4 |
|
|
5.6% |
|
|
17.5 |
|
|
|
16.6 |
|
|
5.4% |
General expense |
|
51.6 |
|
|
|
63.4 |
|
|
(18.6)% |
|
|
173.3 |
|
|
|
185.8 |
|
|
(6.7)% |
Total nonmanufacturing expenses |
|
75.4 |
|
|
|
89.3 |
|
|
(15.6)% |
|
|
245.4 |
|
|
|
263.0 |
|
|
(6.7)% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
— |
|
|
|
401.0 |
|
|
N.M. |
|
|
— |
|
|
|
401.0 |
|
|
N.M. |
Restructuring and other impairment expense |
|
11.2 |
|
|
|
16.3 |
|
|
(31.3)% |
|
|
37.4 |
|
|
|
17.6 |
|
|
N.M. |
Operating profit (loss) |
|
7.0 |
|
|
|
(419.9 |
) |
|
N.M. |
|
|
3.7 |
|
|
|
(411.7 |
) |
|
N.M. |
Interest expense |
|
18.3 |
|
|
|
16.8 |
|
|
8.9% |
|
|
55.0 |
|
|
|
48.8 |
|
|
12.7% |
Other expense, net |
|
(12.7 |
) |
|
|
(0.3 |
) |
|
N.M. |
|
|
(12.1 |
) |
|
|
(3.6 |
) |
|
N.M. |
Loss from continuing operations before income taxes |
|
(24.0 |
) |
|
|
(437.0 |
) |
|
(94.5)% |
|
|
(63.4 |
) |
|
|
(464.1 |
) |
|
(86.3)% |
Income tax expense (benefit), net |
|
(3.2 |
) |
|
|
27.3 |
|
|
N.M. |
|
|
(13.2 |
) |
|
|
30.0 |
|
|
N.M. |
Net loss from continuing operations |
|
(20.8 |
) |
|
|
(464.3 |
) |
|
(95.5)% |
|
|
(50.2 |
) |
|
|
(494.1 |
) |
|
(89.8)% |
Net income from discontinued operations |
|
— |
|
|
|
9.3 |
|
|
N.M. |
|
|
— |
|
|
|
26.9 |
|
|
N.M. |
Net loss |
|
(20.8 |
) |
|
|
(455.0 |
) |
|
(95.4)% |
|
|
(50.2 |
) |
|
|
(467.2 |
) |
|
(89.3)% |
Dividends to participating securities |
|
(0.1 |
) |
|
|
(0.5 |
) |
|
(80.0)% |
|
|
(0.2 |
) |
|
|
(0.7 |
) |
|
(71.4)% |
Net loss attributable to Common Stockholders |
$ |
(20.9 |
) |
|
$ |
(455.5 |
) |
|
(95.4)% |
|
$ |
(50.4 |
) |
|
$ |
(467.9 |
) |
|
(89.2)% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net loss per share - basic: |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Loss per share from continuing operations |
$ |
(0.38 |
) |
|
$ |
(8.50 |
) |
|
(95.5)% |
|
$ |
(0.93 |
) |
|
$ |
(9.06 |
) |
|
(89.7)% |
Income per share from discontinued operations |
|
— |
|
|
|
0.17 |
|
|
N.M. |
|
|
— |
|
|
|
0.49 |
|
|
N.M. |
Basic |
$ |
(0.38 |
) |
|
$ |
(8.33 |
) |
|
(95.4)% |
|
$ |
(0.93 |
) |
|
$ |
(8.57 |
) |
|
(89.1)% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net loss per share – diluted: |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Loss per share from continuing operations |
$ |
(0.38 |
) |
|
$ |
(8.50 |
) |
|
(95.5)% |
|
$ |
(0.93 |
) |
|
$ |
(9.06 |
) |
|
(89.7)% |
Income per share from discontinued operations |
|
— |
|
|
|
0.17 |
|
|
N.M. |
|
|
— |
|
|
|
0.49 |
|
|
N.M. |
Diluted |
$ |
(0.38 |
) |
|
$ |
(8.33 |
) |
|
(95.4)% |
|
$ |
(0.93 |
) |
|
$ |
(8.57 |
) |
|
(89.1)% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Basic |
|
54,327,500 |
|
|
|
54,659,100 |
|
|
|
|
|
54,305,800 |
|
|
|
54,600,100 |
|
|
|
Diluted |
|
54,327,500 |
|
|
|
54,659,100 |
|
|
|
|
|
54,305,800 |
|
|
|
54,600,100 |
|
|
|
|
|
||||||||||||||||||
N.M. - Not Meaningful |
|
|
CONSOLIDATED BALANCE SHEETS (in millions) (Unaudited) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Cash and cash equivalents |
$ |
162.2 |
|
$ |
120.2 |
||
Accounts receivable, net |
|
208.5 |
|
|
176.5 |
||
Inventories, net |
|
354.3 |
|
|
352.9 |
||
Income taxes receivable |
|
16.6 |
|
|
30.6 |
||
Other current assets |
|
35.7 |
|
|
32.3 |
||
Total current assets |
|
777.3 |
|
|
712.5 |
||
Property, plant and equipment, net |
|
635.5 |
|
|
672.5 |
||
Finance lease right-of-use assets |
|
17.3 |
|
|
18.2 |
||
Operating lease right-of-use assets |
|
44.6 |
|
|
45.6 |
||
Deferred income tax benefits |
|
10.4 |
|
|
6.4 |
||
|
|
475.6 |
|
|
474.1 |
||
Intangible assets, net |
|
585.5 |
|
|
631.3 |
||
Other assets |
|
76.9 |
|
|
81.8 |
||
Total assets |
$ |
2,623.1 |
|
$ |
2,642.4 |
||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current debt |
$ |
2.8 |
|
$ |
2.8 |
||
Finance lease liabilities |
|
1.6 |
|
|
1.4 |
||
Operating lease liabilities |
|
9.5 |
|
|
9.9 |
||
Accounts payable |
|
172.7 |
|
|
139.3 |
||
Income taxes payable |
|
10.1 |
|
|
14.3 |
||
Accrued expenses and other current liabilities |
|
131.3 |
|
|
113.7 |
||
Total current liabilities |
|
328.0 |
|
|
281.4 |
||
Long-term debt |
|
1,140.6 |
|
|
1,101.8 |
||
Finance lease liabilities, noncurrent |
|
17.2 |
|
|
18.2 |
||
Operating lease liabilities, noncurrent |
|
34.8 |
|
|
35.3 |
||
Long-term income tax payable |
|
— |
|
|
7.7 |
||
Pension and other postretirement benefits |
|
58.5 |
|
|
62.2 |
||
Deferred income tax liabilities |
|
116.1 |
|
|
142.3 |
||
Other liabilities |
|
45.6 |
|
|
44.4 |
||
Total liabilities |
|
1,740.8 |
|
|
1,693.3 |
||
Stockholders’ equity: |
|
|
|
||||
Preferred stock, |
|
— |
|
|
— |
||
Common stock, |
|
5.4 |
|
|
5.4 |
||
Additional paid-in-capital |
|
671.9 |
|
|
669.6 |
||
Retained earnings |
|
168.3 |
|
|
235.0 |
||
Accumulated other comprehensive income, net of tax |
|
36.7 |
|
|
39.1 |
||
Total stockholders’ equity |
|
882.3 |
|
|
949.1 |
||
Total liabilities and stockholders’ equity |
$ |
2,623.1 |
|
$ |
2,642.4 |
CONSOLIDATED STATEMENTS OF CASH FLOW FROM CONTINUING OPERATIONS (in millions) (Unaudited) |
|||||||
|
Nine Months Ended |
||||||
|
|
2024 |
|
|
|
2023 |
|
Operating |
|
|
|
||||
Loss from continuing operations |
$ |
(50.2 |
) |
|
$ |
(494.1 |
) |
Non-cash items included in net loss: |
|
|
|
||||
Depreciation and amortization |
|
108.4 |
|
|
|
112.4 |
|
Amortization of deferred issuance costs |
|
5.9 |
|
|
|
5.6 |
|
|
|
— |
|
|
|
401.0 |
|
Asset impairments |
|
16.2 |
|
|
|
14.8 |
|
Deferred income tax |
|
(22.2 |
) |
|
|
24.9 |
|
Pension and other postretirement benefits |
|
(4.5 |
) |
|
|
(10.4 |
) |
Stock-based compensation |
|
8.7 |
|
|
|
9.3 |
|
Loss on sale of assets |
|
9.7 |
|
|
|
— |
|
(Gain) loss on foreign currency transactions |
|
3.0 |
|
|
|
(1.2 |
) |
Other non-cash items |
|
(2.9 |
) |
|
|
(7.3 |
) |
Other operating |
|
(2.2 |
) |
|
|
(3.8 |
) |
Net changes in operating working capital |
|
0.8 |
|
|
|
(13.4 |
) |
Net cash provided by operating activities of: |
|
|
|
||||
Continuing operations |
|
70.7 |
|
|
|
37.8 |
|
Discontinued operations |
|
— |
|
|
|
14.6 |
|
Net cash provided by operations |
|
70.7 |
|
|
|
52.4 |
|
Investing |
|
|
|
||||
Capital spending |
|
(32.9 |
) |
|
|
(49.4 |
) |
Capitalized software costs |
|
(0.5 |
) |
|
|
(0.5 |
) |
Proceeds from sale of assets |
|
4.5 |
|
|
|
— |
|
Cash received from (paid on) settlement of cross-currency swap contracts |
|
(1.7 |
) |
|
|
— |
|
Other investing |
|
1.2 |
|
|
|
0.5 |
|
Net cash used in investing of: |
|
|
|
||||
Continuing operations |
|
(29.4 |
) |
|
|
(49.4 |
) |
Discontinued operations |
|
(12.0 |
) |
|
|
(8.8 |
) |
Net cash used in investing |
|
(41.4 |
) |
|
|
(58.2 |
) |
Financing |
|
|
|
||||
Cash dividends paid |
|
(16.2 |
) |
|
|
(49.8 |
) |
Proceeds from long-term debt |
|
127.0 |
|
|
|
180.0 |
|
Payments on long-term debt |
|
(97.0 |
) |
|
|
(134.2 |
) |
Payments for debt issuance costs |
|
— |
|
|
|
(1.5 |
) |
Payments on financing lease obligations |
|
(0.8 |
) |
|
|
(0.7 |
) |
Purchases of common stock |
|
(0.8 |
) |
|
|
(7.0 |
) |
Net cash provided by (used in) financing of: |
|
|
|
||||
Continuing operations |
|
12.2 |
|
|
|
(13.2 |
) |
Discontinued operations |
|
— |
|
|
|
(0.9 |
) |
Net cash provided by (used in) financing |
|
12.2 |
|
|
|
(14.1 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
0.5 |
|
|
|
(0.9 |
) |
Increase (decrease) in cash and cash equivalents |
|
42.0 |
|
|
|
(20.8 |
) |
Cash and cash equivalents at beginning of period |
|
120.2 |
|
|
|
124.4 |
|
Cash and cash equivalents at end of period |
$ |
162.2 |
|
|
$ |
103.6 |
|
|
BUSINESS SEGMENT REPORTING FROM CONTINUING OPERATIONS |
(in millions) |
(Unaudited) |
|
NOTE REGARDING SEGMENT REPORTING AND COMPARABILITY |
|
The Company filed a Current Report on Form 8-K/A on |
|
As part of the organizational realignment effective during the first quarter of 2024, we have reorganized into two new reportable segments: (1) Filtration & Advanced Materials ("FAM") focused primarily on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions ("SAS"), focused primarily on tapes, labels, liners, specialty paper, packaging and healthcare solutions. The change in reportable segments reflects the realignment of segment level management and the related internal review of our operating segments. The prior period segment results have been revised to align with our current segment reporting structure and is presented on a continuing operations basis. |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||||
|
2024 |
|
2023 |
|
% Change |
|
2024 |
|
2023 |
|
% Change |
||||||||||
FAM |
$ |
189.6 |
|
$ |
195.8 |
|
(3.2 |
)% |
|
$ |
598.7 |
|
$ |
628.1 |
|
(4.7 |
)% |
||||
SAS |
|
308.9 |
|
|
302.4 |
|
2.1 |
% |
|
|
923.8 |
|
|
945.6 |
|
(2.3 |
)% |
||||
Total Consolidated |
$ |
498.5 |
|
$ |
498.2 |
|
0.1 |
% |
|
$ |
1,522.5 |
|
$ |
1,573.7 |
|
(3.3 |
)% |
Operating Profit (Loss) from Continuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||||||||||
|
|
|
|
|
Return on |
|
|
|
|
|
Return on |
||||||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||||||
FAM |
$ |
19.9 |
|
|
$ |
22.6 |
|
|
10.5 |
% |
|
11.5 |
% |
|
$ |
59.7 |
|
|
$ |
78.3 |
|
|
10.0 |
% |
|
12.5 |
% |
SAS |
|
10.3 |
|
|
|
(405.8 |
) |
|
3.3 |
% |
|
(134.2 |
)% |
|
|
30.1 |
|
|
|
(385.4 |
) |
|
3.3 |
% |
|
(40.8 |
)% |
Unallocated |
|
(23.2 |
) |
|
|
(36.7 |
) |
|
(4.7 |
)% |
|
(7.4 |
)% |
|
|
(86.1 |
) |
|
|
(104.6 |
) |
|
(5.7 |
)% |
|
(6.6 |
)% |
Total Consolidated |
$ |
7.0 |
|
|
$ |
(419.9 |
) |
|
1.4 |
% |
|
(84.3 |
)% |
|
$ |
3.7 |
|
|
$ |
(411.7 |
) |
|
0.2 |
% |
|
(26.2 |
)% |
Non-GAAP Adjustments to Operating Profit (Loss) |
|
|
|
|
|
|
|
||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
FAM - Amortization of intangibles and other purchase accounting adjustments |
$ |
8.7 |
|
$ |
8.4 |
|
$ |
26.0 |
|
|
$ |
25.1 |
|||
FAM - Restructuring, restructuring related, impairment, and other expenses |
|
0.8 |
|
|
1.1 |
|
|
5.2 |
|
|
|
2.4 |
|||
FAM - Organizational realignment and integration costs(2) |
|
0.1 |
|
|
— |
|
|
0.2 |
|
|
|
— |
|||
SAS - Amortization of intangibles and other purchase accounting adjustments |
|
7.1 |
|
|
7.2 |
|
|
21.3 |
|
|
|
21.8 |
|||
SAS - Restructuring, restructuring related, impairment, and other expenses |
|
10.5 |
|
|
418.9 |
|
|
28.2 |
|
|
|
419.3 |
|||
SAS - Organizational realignment and integration costs(2) |
|
— |
|
|
— |
|
|
(0.1 |
) |
|
|
— |
|||
Unallocated - Restructuring, restructuring related, impairment, and other expenses |
|
— |
|
|
— |
|
|
3.4 |
|
|
|
1.1 |
|||
Unallocated - Organizational realignment and integration costs(2) |
|
1.5 |
|
|
9.2 |
|
|
8.0 |
|
|
|
28.7 |
|||
Unallocated - Divestiture costs |
|
0.4 |
|
|
5.3 |
|
|
3.6 |
|
|
|
5.3 |
|||
Unallocated - Financing fees(1) |
|
2.3 |
|
|
2.4 |
|
|
6.9 |
|
|
|
2.4 |
|||
Unallocated - Amortization of cloud-based software costs |
|
0.1 |
|
|
— |
|
|
0.3 |
|
|
|
— |
|||
Total Consolidated |
$ |
31.5 |
|
$ |
452.5 |
|
$ |
103.0 |
|
|
$ |
506.1 |
|||
(1) Financing fees incurred for the Receivables Sales Agreement for the three and nine months ended |
|||||||||||||||
(2) Costs associated with the organizational realignment plan (“the Plan”) announced on |
Adjusted Operating Profit from Continuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||||||||||
|
|
|
|
|
Return on |
|
|
|
|
|
Return on |
||||||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||||||
FAM |
$ |
29.5 |
|
|
$ |
32.1 |
|
|
15.6 |
% |
|
16.4 |
% |
|
$ |
91.1 |
|
|
$ |
105.8 |
|
|
15.2 |
% |
|
16.8 |
% |
SAS |
|
27.9 |
|
|
|
20.3 |
|
|
9.0 |
% |
|
6.7 |
% |
|
|
79.5 |
|
|
|
55.7 |
|
|
8.6 |
% |
|
5.9 |
% |
Unallocated |
|
(18.9 |
) |
|
|
(19.8 |
) |
|
(3.8 |
)% |
|
(4.0 |
)% |
|
|
(63.9 |
) |
|
|
(67.1 |
) |
|
(4.2 |
)% |
|
(4.3 |
)% |
Total Consolidated |
$ |
38.5 |
|
|
$ |
32.6 |
|
|
7.7 |
% |
|
6.5 |
% |
|
$ |
106.7 |
|
|
$ |
94.4 |
|
|
7.0 |
% |
|
6.0 |
% |
Non-GAAP Adjustments to Adjusted Operating Profit |
|
|
|
|
|
|
|
||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
FAM - Depreciation |
$ |
6.7 |
|
$ |
7.0 |
|
$ |
20.2 |
|
$ |
20.6 |
||||
FAM - Stock-based compensation(1) |
|
0.3 |
|
|
0.1 |
|
|
0.7 |
|
|
0.3 |
||||
SAS - Depreciation |
|
12.6 |
|
|
13.5 |
|
|
39.4 |
|
|
41.5 |
||||
SAS - Stock-based compensation(1) |
|
0.5 |
|
|
0.4 |
|
|
0.6 |
|
|
0.4 |
||||
Unallocated - Depreciation |
|
0.6 |
|
|
0.9 |
|
|
1.5 |
|
|
3.0 |
||||
Unallocated - Stock-based compensation(1) |
|
1.6 |
|
|
0.9 |
|
|
4.1 |
|
|
3.2 |
||||
Total Consolidated |
$ |
22.3 |
|
$ |
22.8 |
|
$ |
66.5 |
|
$ |
69.0 |
||||
(1) Stock-based compensation excludes stock-based compensation included in restructuring and integration costs. |
Adjusted EBITDA from Continuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||||||||||
|
|
|
|
|
Return on |
|
|
|
|
|
Return on |
||||||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||||||
FAM |
$ |
36.5 |
|
|
$ |
39.2 |
|
|
19.3 |
% |
|
20.0 |
% |
|
$ |
112.0 |
|
|
$ |
126.7 |
|
|
18.7 |
% |
|
20.2 |
% |
SAS |
|
41.0 |
|
|
|
34.2 |
|
|
13.3 |
% |
|
11.3 |
% |
|
|
119.5 |
|
|
|
97.6 |
|
|
12.9 |
% |
|
10.3 |
% |
Unallocated |
|
(16.7 |
) |
|
|
(18.0 |
) |
|
(3.4 |
)% |
|
(3.6 |
)% |
|
|
(58.3 |
) |
|
|
(60.9 |
) |
|
(3.8 |
)% |
|
(3.9 |
)% |
Total Consolidated |
$ |
60.8 |
|
|
$ |
55.4 |
|
|
12.2 |
% |
|
11.1 |
% |
|
$ |
173.2 |
|
|
$ |
163.4 |
|
|
11.4 |
% |
|
10.4 |
% |
Non-GAAP Reconciliation of Organic Net Sales Growth |
|||||||||||
|
|
|
|
|
|
||||||
|
FAM |
|
SAS |
|
Consolidated |
||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
|
$ |
195.8 |
|
|
$ |
302.4 |
|
|
$ |
498.2 |
|
Divestiture/closure adjustments |
|
— |
|
|
|
(6.5 |
) |
|
|
(6.5 |
) |
|
$ |
195.8 |
|
|
$ |
295.9 |
|
|
$ |
491.7 |
|
|
|
|
|
|
|
||||||
|
$ |
189.6 |
|
|
$ |
308.9 |
|
|
$ |
498.5 |
|
Divestiture/closure adjustments |
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
189.6 |
|
|
$ |
308.9 |
|
|
$ |
498.5 |
|
Organic growth |
|
(3.2 |
)% |
|
|
4.4 |
% |
|
|
1.4 |
% |
|
|
|
|
|
|
||||||
Currency effects on 2024 |
$ |
0.9 |
|
|
$ |
0.7 |
|
|
$ |
1.6 |
|
|
$ |
188.7 |
|
|
$ |
308.2 |
|
|
$ |
496.9 |
|
Organic constant currency growth |
|
(3.6 |
)% |
|
|
4.2 |
% |
|
|
1.1 |
% |
|
|
|
|||||||||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA |
|
|
|||||||||||||
(in millions, except per share amounts) |
|
|
|||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Operating profit (loss) from continuing operations |
$ |
7.0 |
|
|
$ |
(419.9 |
) |
|
$ |
3.7 |
|
|
$ |
(411.7 |
) |
Plus: Restructuring, restructuring related, impairment, and other expenses |
|
11.3 |
|
|
|
19.0 |
|
|
|
36.8 |
|
|
|
21.8 |
|
Plus: |
|
— |
|
|
|
401.0 |
|
|
|
— |
|
|
|
401.0 |
|
Plus: Purchase accounting adjustments |
|
15.8 |
|
|
|
15.6 |
|
|
|
47.3 |
|
|
|
46.9 |
|
Plus: Organizational realignment and integration costs |
|
1.6 |
|
|
|
9.2 |
|
|
|
8.1 |
|
|
|
28.7 |
|
Plus: Divestiture costs |
|
0.4 |
|
|
|
5.3 |
|
|
|
3.6 |
|
|
|
5.3 |
|
Plus: Financing fees |
|
2.3 |
|
|
|
2.4 |
|
|
|
6.9 |
|
|
|
2.4 |
|
Plus: Amortization of cloud-based software costs |
|
0.1 |
|
|
|
— |
|
|
|
0.3 |
|
|
|
— |
|
Adjusted Operating Profit from continuing operations |
$ |
38.5 |
|
|
$ |
32.6 |
|
|
$ |
106.7 |
|
|
$ |
94.4 |
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) from continuing operations |
$ |
(20.8 |
) |
|
$ |
(464.3 |
) |
|
$ |
(50.2 |
) |
|
$ |
(494.1 |
) |
Plus: Restructuring, restructuring related, impairment, and other expenses |
|
10.7 |
|
|
|
16.8 |
|
|
|
31.8 |
|
|
|
18.9 |
|
Plus: |
|
— |
|
|
|
401.0 |
|
|
|
— |
|
|
|
401.0 |
|
Plus: Gain/loss on sale of assets |
|
5.8 |
|
|
|
— |
|
|
|
5.8 |
|
|
|
— |
|
Plus: Purchase accounting adjustments |
|
12.2 |
|
|
|
13.1 |
|
|
|
36.5 |
|
|
|
36.7 |
|
Plus: Litigation/tax settlement |
|
— |
|
|
|
1.2 |
|
|
|
— |
|
|
|
4.9 |
|
Plus: Organizational realignment and integration costs |
|
1.2 |
|
|
|
7.5 |
|
|
|
6.1 |
|
|
|
22.4 |
|
Plus: Divestiture costs |
|
0.3 |
|
|
|
4.1 |
|
|
|
2.8 |
|
|
|
4.0 |
|
Plus: Other |
|
1.1 |
|
|
|
— |
|
|
|
1.1 |
|
|
|
— |
|
Less: Luxembourg valuation allowance release |
|
— |
|
|
|
31.7 |
|
|
|
— |
|
|
|
31.7 |
|
Plus: Reversal of valuation allowance on prior year tax credits |
|
— |
|
|
|
6.4 |
|
|
|
— |
|
|
|
6.4 |
|
Plus: Tax legislative changes, net of other discrete items |
|
0.5 |
|
|
|
(6.3 |
) |
|
|
(2.8 |
) |
|
|
2.2 |
|
Adjusted Income from continuing operations |
$ |
11.0 |
|
|
$ |
11.2 |
|
|
$ |
31.1 |
|
|
$ |
34.1 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share from continuing operations - diluted |
$ |
(0.38 |
) |
|
$ |
(8.50 |
) |
|
$ |
(0.93 |
) |
|
$ |
(9.06 |
) |
Plus: Restructuring, restructuring related, impairment, and other expenses |
|
0.20 |
|
|
|
0.32 |
|
|
|
0.58 |
|
|
|
0.36 |
|
Plus: |
|
— |
|
|
|
7.30 |
|
|
|
— |
|
|
|
7.30 |
|
Plus: Gain/loss on sale of assets |
|
0.11 |
|
|
|
— |
|
|
|
0.11 |
|
|
|
— |
|
Plus: Purchase accounting adjustments |
|
0.22 |
|
|
|
0.23 |
|
|
|
0.67 |
|
|
|
0.67 |
|
Plus: Litigation/tax settlement |
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.09 |
|
Plus: Organizational realignment and integration costs |
|
0.02 |
|
|
|
0.14 |
|
|
|
0.11 |
|
|
|
0.42 |
|
Plus: Divestiture costs |
|
0.01 |
|
|
|
0.08 |
|
|
|
0.05 |
|
|
|
0.08 |
|
Plus: Other |
|
0.02 |
|
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
Less: Luxembourg valuation allowance release |
|
— |
|
|
|
0.59 |
|
|
|
— |
|
|
|
0.59 |
|
Plus: Reversal of valuation allowance on prior year tax credits |
|
— |
|
|
|
0.13 |
|
|
|
— |
|
|
|
0.12 |
|
Plus: Tax legislative changes, net of other discrete items |
|
0.01 |
|
|
|
(0.10 |
) |
|
|
(0.05 |
) |
|
|
0.05 |
|
Adjusted Earnings Per Share from continuing operations - diluted |
$ |
0.21 |
|
|
$ |
0.21 |
|
|
$ |
0.56 |
|
|
$ |
0.62 |
|
|
|
|
|||||||||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA |
|
|
|||||||||||||
(in millions, except per share amounts) |
|
|
|||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Net loss from continuing operations |
$ |
(20.8 |
) |
|
$ |
(464.3 |
) |
|
$ |
(50.2 |
) |
|
$ |
(494.1 |
) |
Plus: Interest expense |
|
18.3 |
|
|
|
16.8 |
|
|
|
55.0 |
|
|
|
48.8 |
|
Plus: Financing fees |
|
2.3 |
|
|
|
2.4 |
|
|
|
6.9 |
|
|
|
2.4 |
|
Plus: Provision for income taxes |
|
(3.2 |
) |
|
|
27.3 |
|
|
|
(13.2 |
) |
|
|
30.0 |
|
Plus: Depreciation & amortization |
|
35.7 |
|
|
|
36.9 |
|
|
|
108.4 |
|
|
|
110.5 |
|
Plus: Amortization of cloud-based software costs |
|
0.1 |
|
|
|
— |
|
|
|
0.3 |
|
|
|
— |
|
Plus: Stock compensation expense |
|
2.4 |
|
|
|
1.4 |
|
|
|
5.4 |
|
|
|
4.0 |
|
Plus: Inventory step up expense |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1.4 |
|
Plus: Restructuring, restructuring related, impairment, and other expenses |
|
11.3 |
|
|
|
16.3 |
|
|
|
36.8 |
|
|
|
17.6 |
|
Plus: |
|
— |
|
|
|
401.0 |
|
|
|
— |
|
|
|
401.0 |
|
Plus: Other restructuring related expense |
|
— |
|
|
|
2.8 |
|
|
|
— |
|
|
|
4.2 |
|
Plus: Organizational realignment and integration costs |
|
1.6 |
|
|
|
9.2 |
|
|
|
8.1 |
|
|
|
28.7 |
|
Plus: Divestiture costs |
|
0.4 |
|
|
|
5.3 |
|
|
|
3.6 |
|
|
|
5.3 |
|
Plus: Litigation/tax settlement |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4.9 |
|
Plus: Other income (expense), net |
|
12.7 |
|
|
|
0.3 |
|
|
|
12.1 |
|
|
|
(1.3 |
) |
Adjusted EBITDA from continuing operations |
$ |
60.8 |
|
|
$ |
55.4 |
|
|
$ |
173.2 |
|
|
$ |
163.4 |
|
|
|
|
|
|
|
|
|
||||||||
Cash used in operating activities of continuing operations |
$ |
37.6 |
|
|
$ |
32.3 |
|
|
$ |
70.7 |
|
|
$ |
37.8 |
|
Less: Capital spending |
|
(12.1 |
) |
|
|
(14.7 |
) |
|
|
(32.9 |
) |
|
|
(49.4 |
) |
Less: Capitalized software costs |
|
(0.4 |
) |
|
|
— |
|
|
|
(0.5 |
) |
|
|
(0.5 |
) |
Less: Cloud-based software costs |
|
(1.2 |
) |
|
|
— |
|
|
|
(2.2 |
) |
|
|
— |
|
Free Cash Flow from continuing operations |
$ |
23.9 |
|
|
$ |
17.6 |
|
|
$ |
35.1 |
|
|
$ |
(12.1 |
) |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Total Debt |
|
|
|
|
$ |
1,143.4 |
|
|
$ |
1,104.6 |
|
||||
Less: Cash |
|
|
|
|
|
162.2 |
|
|
|
120.2 |
|
||||
Net Debt from continuing operations |
|
|
|
|
$ |
981.2 |
|
|
$ |
984.4 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106250893/en/
Director, Investor Relations
+1-770-569-4229
Website: http://www.mativ.com
Source: